JP2008539164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539164A5 JP2008539164A5 JP2007555371A JP2007555371A JP2008539164A5 JP 2008539164 A5 JP2008539164 A5 JP 2008539164A5 JP 2007555371 A JP2007555371 A JP 2007555371A JP 2007555371 A JP2007555371 A JP 2007555371A JP 2008539164 A5 JP2008539164 A5 JP 2008539164A5
- Authority
- JP
- Japan
- Prior art keywords
- lysine
- peptide
- influenza virus
- histidine
- terminal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 35
- 235000018977 lysine Nutrition 0.000 claims 31
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 27
- 239000004472 Lysine Substances 0.000 claims 27
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 26
- 241000712461 unidentified influenza virus Species 0.000 claims 21
- 238000000034 method Methods 0.000 claims 18
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 16
- 235000001014 amino acid Nutrition 0.000 claims 13
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims 13
- 150000001413 amino acids Chemical class 0.000 claims 10
- 230000001225 therapeutic effect Effects 0.000 claims 10
- 229960004854 viral vaccine Drugs 0.000 claims 10
- 241000700605 Viruses Species 0.000 claims 9
- 230000000069 prophylactic effect Effects 0.000 claims 9
- 235000018102 proteins Nutrition 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 125000000539 amino acid group Chemical group 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical group OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 4
- -1 lysine amino acids Chemical class 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- JXYWFNAQESKDNC-BTJKTKAUSA-N (z)-4-hydroxy-4-oxobut-2-enoate;2-[(4-methoxyphenyl)methyl-pyridin-2-ylamino]ethyl-dimethylazanium Chemical group OC(=O)\C=C/C(O)=O.C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 JXYWFNAQESKDNC-BTJKTKAUSA-N 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65308305P | 2005-02-16 | 2005-02-16 | |
| PCT/US2005/014443 WO2005104754A2 (en) | 2004-04-28 | 2005-04-28 | System and method for identifying complex patterns of amino acids |
| PCT/US2006/005343 WO2006088962A2 (en) | 2005-02-16 | 2006-02-16 | Replikin peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008539164A JP2008539164A (ja) | 2008-11-13 |
| JP2008539164A5 true JP2008539164A5 (enExample) | 2009-04-09 |
Family
ID=36917023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007555371A Pending JP2008539164A (ja) | 2005-02-16 | 2006-02-16 | レプリキンペプチド及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1859063A4 (enExample) |
| JP (1) | JP2008539164A (enExample) |
| AU (1) | AU2006214332B2 (enExample) |
| CA (1) | CA2598381A1 (enExample) |
| IL (1) | IL185308A0 (enExample) |
| NZ (1) | NZ560415A (enExample) |
| SG (1) | SG160327A1 (enExample) |
| WO (1) | WO2006088962A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7420028B2 (en) | 2001-03-27 | 2008-09-02 | Samuel Bogoch | Replikins and methods of identifying replikin-containing sequences |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| EP2027146B1 (en) * | 2006-05-30 | 2012-10-03 | Bogoch, Samuel, Dr. | Replikin peptides and uses thereof |
| US8050871B2 (en) | 2006-10-24 | 2011-11-01 | Samuel Bogoch | Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus |
| WO2008143717A2 (en) | 2007-01-18 | 2008-11-27 | Samuel Bogoch | Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| US9408902B2 (en) | 2007-05-30 | 2016-08-09 | Samuel Bogoch | Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
| WO2009132209A2 (en) * | 2008-04-23 | 2009-10-29 | Samuel Bogoch | Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| WO2010017514A2 (en) * | 2008-08-08 | 2010-02-11 | Samuel Bogoch | Methods of predicting cancer lethality using replikin counts |
| US9233148B2 (en) * | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
| WO2010123519A1 (en) * | 2009-04-23 | 2010-10-28 | Samuel Bogoch | Replikin-sequences for preventing/treating influenza and determining infectivity/lethality |
| EP2734226A2 (en) | 2011-07-20 | 2014-05-28 | Samuel Bogoch | Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| US20130243803A1 (en) | 2012-03-09 | 2013-09-19 | Samuel Bogoch | Therapies, vaccines, and predictive methods for infectious salmon anemia virus |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0221748A3 (en) | 1985-11-01 | 1988-10-12 | Samuel Dr. Bogoch | A process for the production of human antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US6242578B1 (en) | 1994-02-17 | 2001-06-05 | Samuel Bogoch | Aglyco products and methods of use |
| US7420028B2 (en) * | 2001-03-27 | 2008-09-02 | Samuel Bogoch | Replikins and methods of identifying replikin-containing sequences |
| US7442761B2 (en) * | 2003-06-06 | 2008-10-28 | Samuel Bogoch | Replikin peptides and uses thereof |
| US11620305B2 (en) | 2021-03-25 | 2023-04-04 | Salesforce.Com, Inc | Ruleset engine for generating homogeneous data sets |
-
2006
- 2006-02-16 AU AU2006214332A patent/AU2006214332B2/en not_active Ceased
- 2006-02-16 SG SG201001000-7A patent/SG160327A1/en unknown
- 2006-02-16 WO PCT/US2006/005343 patent/WO2006088962A2/en not_active Ceased
- 2006-02-16 CA CA002598381A patent/CA2598381A1/en not_active Abandoned
- 2006-02-16 EP EP06735145A patent/EP1859063A4/en not_active Withdrawn
- 2006-02-16 NZ NZ560415A patent/NZ560415A/en not_active IP Right Cessation
- 2006-02-16 JP JP2007555371A patent/JP2008539164A/ja active Pending
-
2007
- 2007-08-16 IL IL185308A patent/IL185308A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hanke et al. | Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime | |
| JP2019526580A5 (enExample) | ||
| JP2008539164A5 (enExample) | ||
| US20070134262A1 (en) | Antigens encoded by alternative reading frames from pathogenic viruses | |
| JP2012509340A5 (enExample) | ||
| JP2008526764A5 (enExample) | ||
| JP2014534202A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2008530245A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| JP2012503011A5 (ja) | 慢性ｃ型肝炎ウイルス感染症のための酵母系免疫治療組成物 | |
| JP2017503482A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| CA2380833A1 (en) | Proteins derived from white spot syndrome virus and uses thereof | |
| CA2419822A1 (en) | Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization | |
| RU2008102930A (ru) | Способы введения вакцин, новые калицивирусы кошки и варианты лечения для иммунизации животных против парвовируса кошки и вируса герпеса кошки | |
| WO2002022664A3 (en) | Antigenic proteins of shrimp white spot syndrome virus and uses thereof | |
| US11732031B2 (en) | Method for producing influenza HA split vaccine | |
| DK200601181A (da) | Fiskevaccine | |
| JP2018533908A5 (enExample) | ||
| MX2023003377A (es) | Compuesto para aumentar la eficacia de los vectores virales. | |
| JP2010535504A5 (enExample) |